Firebrick Pharma (ASX: FRE) is building more than just a nasal spray for the common cold. The company is now expanding the Nasodine story with a throat spray. In this KapitaList interview, Dr Peter Molloy explains the thinking behind the product and how Firebrick Pharma is on the verge of having the two largest markets covered.
